Gastroenterology
Volume 138, Issue 1 , Pages 30-33, January 2010

Reducing the Gastrointestinal Risks of Low-Dose Aspirin

  • Byron Cryer

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Byron Cryer, MD, Department of Medicine, Division of Digestive Diseases, Dallas VA Medical Center, University of Texas Southwestern Medical School, 4500 S Lancaster Rd. (111B1), Dallas, TX 75216

Division of Gastroenterology, Department of Medicine, Dallas VA Medical Center, University of Texas Southwestern Medical School, Dallas, Texas

published online 23 November 2009.

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Conflicts of interest The author discloses the following: he has current consulting relationships with AstraZeneca, Inc, Horizon Therapeutics, McNeil Consumer Products, NiCox Inc, PLx Pharma, Pfizer Inc. and POZEN, Inc. and that he has received current research grants from PLx Pharma and Pfizer Inc.

PII: S0016-5085(09)02049-6

doi:10.1053/j.gastro.2009.11.032

Refers to article:

  • Additional Online Content AvailableEditorial Accompanies ArticleVideo Abstract Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions , 19 October 2009

    Fook–Hong Ng, Siu–Yin Wong, Kwok–Fai Lam, Wai–Ming Chu, Pierre Chan, Yuk–Hei Ling, Carolyn Kng, Wai–Cheung Yuen, Yuk–Kong Lau, Ambrose Kwan, Benjamin C.Y. Wong
    Gastroenterology January 2010 (Vol. 138, Issue 1, Pages 82-88)

Gastroenterology
Volume 138, Issue 1 , Pages 30-33, January 2010

Article Tools

* Image Usage & Resolution